Search

Global Health Watch: CDC, NIH, FDA Hit Hard as HHS Begins Workforce Reductions

This week’s issue covers drastic cuts across the US Department of Health and Human Services (HHS), where a dramatic 20% downsizing effort is underway. The ripple effects are vast—gutting HIV prevention, infectious disease research, and vaccine development, while threatening the stability and viability of the workforce that sustains US public health and biomedical research.

AVAC Condemns HHS Mass Layoffs

AVAC condemns the US administration’s ongoing reduction in force of the US Department of Health and Human Services, which oversees 13 agencies, including the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health.

AVAC Condemns HHS Mass Layoffs

AVAC condemns the US administration’s ongoing reduction in force of the US Department of Health and Human Services, which oversees 13 agencies, including the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health.

Lenacapavir Regulatory Approval

The Role of PEPFAR in HIV Prevention

AVAC Senior Program Manager for Policy, John Meade Jr., describes PEPFAR’s historic legacy and strongly argues for its continued importance in the face of attacks by the new US administration. This piece appears in The Broadsheet, the magazine published by the Congressional Black Caucus Health Braintrust.

Cabotegravir Implementation

Dapivirine Vaginal Ring Implementation

Cabotegravir Volume

Dapivirine Vaginal Ring Volume

Cabotegravir Regulatory Approval